Empatica is at the forefront of health monitoring technology, particularly through its FDA-cleared Empatica Health Monitoring Platform and the EmbracePlus wearable device. This platform is designed to provide accurate, continuous health insights, making it a valuable tool for researchers and clinicians. The EmbracePlus device is equipped with multiple sensors that measure various physiological parameters, including pulse rate, skin temperature, and more, enabling the collection of real-world data. The platform supports a wide range of applications, from clinical trials to remote patient monitoring, and is scalable across different therapeutic areas, allowing for simultaneous data collection from thousands of devices globally.

The company has pioneered the development of digital biomarkers, offering over 200 clinically validated measures that can be utilized as digital endpoints in research. Empatica's technology is not only used in numerous studies but has also been referenced in over 12,000 research papers, highlighting its significant impact on advancing scientific knowledge in health monitoring. The integration of the Empatica Cloud API further enhances the platform's capabilities, allowing seamless data flow into existing clinical trial management systems. This comprehensive approach to health monitoring positions Empatica as a leader in the field, facilitating innovative research and improving patient care through advanced wearable technology.

United States

Empatica is an affective computing company, focused on human data analytics. We develop groundbreaking wearable devices with medical quality sensing.
Our technology comprises a set of wristband, software running on smartphone and desktop computing, plus real time syncing with a cloud computing service.

Empatica

Company Details